Category: Kane
-
Perimeter (PINK.V) has developed A.I. that radically improves breast cancer surgery outcomes
There is a tendency in our culture to avoid talking about illness. It’s a downer. It’s bad voodoo. Why rattle the cage? But when people do decide to speak bluntly about illness, the reaction is usually positive. “Breast cancer in women has leap-frogged lung cancer, now accounting for the most cancer diagnoses worldwide – and…
-
Xphyto (XPHY.C) partner/acquisition target achieves major milestone with Covid-19 biosensor candidates
On July 28, 2021 Xphyto Therapeutics (XPHY.C) announced that its acquisition target, 3a-diagnostics GmbH, has identified the first saliva-activated in-mouth biosensor candidates for the detection of a COVID-19 infection. Xphyto Therapeutics is a bioscience accelerator focused on next-generation drug delivery, diagnostic and new active pharmaceutical ingredient investment opportunities. 3a-diagnostics is currently a commercial partner of…
-
Diagnos (ADK.V) opens A.I screening clinics in diabetes-ravaged Saudi Arabia
On July 22, 2021 Diagnos (ADK.V) announced the official opening of the initial clinics at the Magrabi Hospital in Saudi Arabia. DIAGNOS specialises in early detection of health problems based on its FLAIRE artificial intelligence (AI) platform. The FLAIRE platform is used in applications such as CARA (Computer Assisted Retina Analysis). CARA’s artificial intelligence-based image…
-
Plurilock (PLUR.V) inks deal with U.S. Department of Defense completing USD $5.5 million in sales in 3 months
All contracts are not created equal. Let’s call “1” – trivial, and “10” highly significant. CBD lip balm to feature in 3 Czechoslovakian pop-up stores – “1”. Molybdenum explorer engages renowned metallurgy expert – “5”. Cybersecurity company inks deal with U.S. Department of Defense – “10”. On July 15, 2021 Plurilock Security (PLUR.V) received a…
-
GameOn (GET.C) joins Blockparty to integrate prediction games with NFT market
Thirty years ago, advertisers would buy time on NBC and hope that viewers didn’t nod off or go the washroom while the ad was playing. The eye-balls paid for were not the eye-balls delivered. Commercial avoidance technology (PVRs) further severely damaged that model. Social media platforms like Facebook are successful in part because the viewer…
-
Manganese X (MN.V) CEO Martin Kepman explains the new Battery Hill Manganese Resource Estimate
On July 7, 2021 Manganese X (MN.V) announced the first Mineral Resource Estimate for its Battery Hill Manganese Project. Equity Guru jumped on the July 7, 2021 6:30 a.m. Emerging Growth Conference call with the CEO Martin Kepman. Edited remarks from that call are published below, but first let’s zoom out and review why manganese…
-
Bioasis Technologies (BTI.V) stock is on the move – following scientific validation of xB3 platform
Bioasis Technologies’ (BTI.V) xB3 platform is designed to deliver therapeutics across the blood brain barrier. BTI’s proprietary tech is relevant to the treatment of brain cancers and neurodegenerative diseases. Investing in small-cap pharmaceutical companies requires patience. Not every product in the pipeline pans out. Some trials have disappointing outcomes. Many investors can’t handle the zigs…